Ebina, Teresita P.
HRN: 21-84-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
CEFTAZIDIME 1GM (VIAL)
09/10/2023
09/17/2023
IV
1gm
TID
CAP MR
Checking Final Appropriateness
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes